Cargando…

Quantitative efficacy of three antipsychotic drugs for schizophrenia based on a real-world study in China

Atypical antipsychotics exert remarkable long-term efficacy on the personal and social functions of schizophrenic patients. However, quantitative information on the social function of schizophrenic patients treated with atypical antipsychotics is scarce in the current clinical guidelines. In this st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Lei, Li, Yan-ge, He, Shen, Zhang, Yan, Yu, Yi-min, Li, Yan, Wen, Hui, Qiao, Ying, Shen, Yi-feng, Li, Hua-fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470854/ https://www.ncbi.nlm.nih.gov/pubmed/31388088 http://dx.doi.org/10.1038/s41401-019-0285-x

Ejemplares similares

Long-Term Antipsychotic Effectiveness and Comparison of the Efficacy of Monotherapy and Polypharmacy in Schizophrenia: A 3-Years Follow-Up “Real World” Study in China
por: Zhang, Lei, et al.
Publicado: (2022)

Factors That Influence the Prescription of Antipsychotics for Patients with Schizophrenia in China
por: Si, Tian-Mei, et al.
Publicado: (2011)

Study on risk factors of extrapyramidal symptoms induced by antipsychotics and its correlation with symptoms of schizophrenia
por: Weng, Jiajun, et al.
Publicado: (2019)

Aripiprazole in the treatment of acute episode of schizophrenia: a real-world study in China
por: Li, Qian, et al.
Publicado: (2023)

A Real-World Observation of Antipsychotic Effects on Brain Volumes and Intrinsic Brain Activity in Schizophrenia
por: Chen, Yifan, et al.
Publicado: (2022)

Real‐world effectiveness of antipsychotics
por: Tiihonen, J.
Publicado: (2016)

Antipsychotic agents: efficacy and safety in schizophrenia
por: de Araújo, Arão Nogueira, et al.
Publicado: (2012)

Off-label use of antipsychotic medications in psychiatric inpatients in China: a national real-world survey
por: Wang, Juan, et al.
Publicado: (2021)

Variants of GRM7 as risk factor and response to antipsychotic therapy in schizophrenia
por: Liang, Wei, et al.
Publicado: (2020)

T223. REAL WORLD EFFECTIVENESS OF ANTIPSYCHOTIC DRUGS IN PATIENTS WITH SCHIZOPHRENIA: A 10-YEARS RETROSPECTIVE STUDY
por: Lee, Tae Young, et al.
Publicado: (2018)

HSD26 Impact of the COVID-19 Pandemic on Real-World Antipsychotic Treatment Patterns in Patients with Schizophrenia
por: Liu, Z, et al.
Publicado: (2022)

Association Between the COMT Val158Met Polymorphism and Antipsychotic Efficacy in Schizophrenia: An Updated Meta-Analysis
por: Ma, Jingsong, et al.
Publicado: (2021)

Second-Generation Antipsychotics’ Effectiveness and Tolerability: A Review of Real-World Studies in Patients with Schizophrenia and Related Disorders
por: Fabrazzo, Michele, et al.
Publicado: (2022)

A Random Forest Model for Predicting Social Functional Improvement in Chinese Patients with Schizophrenia After 3 Months of Atypical Antipsychotic Monopharmacy: A Cohort Study
por: Li, Yange, et al.
Publicado: (2021)

Perceptions of Family Caregivers of Patients with Schizophrenia Towards Antipsychotics Associated Side-Effects in China:A Qualitative Study
por: Zhou, Hang, et al.
Publicado: (2022)

T232. EFFICACY AND SAFETY OF ANTIDEPRESSANT AUGMENTATION OF ANTIPSYCHOTICS IN SCHIZOPHRENIA
por: Galling, Britta, et al.
Publicado: (2018)

Dietary Policies and Programs: Moving Beyond Efficacy and Into “Real-World” Settings
por: Yi, Stella S., et al.
Publicado: (2021)

Factors Influencing Patient and Caregiver Preferences for Antipsychotic Treatment of Schizophrenia in China: A Discrete Choice Experiment
por: Zhang, Weibo, et al.
Publicado: (2023)

Protocol for a pharmacogenomic study on individualised antipsychotic drug treatment for patients with schizophrenia
por: Su, Yi, et al.
Publicado: (2021)

Association between IL-6 and metabolic syndrome in schizophrenia patients treated with second-generation antipsychotics
por: Fang, Xinyu, et al.
Publicado: (2019)

Characteristics and Spectrum of Cardiotoxicity Induced by Various Antipsychotics: A Real-World Study From 2015 to 2020 Based on FAERS
por: He, Luyao, et al.
Publicado: (2022)

Selection of Suitable Reference Genes for Quantitative Real-Time PCR Normalization in Three Types of Rat Adipose Tissue
por: Zhang, Wan-Xia, et al.
Publicado: (2016)

Impact of Lurasidone and Other Antipsychotics on Body Weight: Real-World, Retrospective, Comparative Study of 15,323 Adults with Schizophrenia
por: Pochiero, Ilena, et al.
Publicado: (2021)

A meta-analysis of effectiveness of real-world studies of antipsychotics in schizophrenia: Are the results consistent with the findings of randomized controlled trials?
por: Katona, Lajos, et al.
Publicado: (2021)

Systematic Review of Real-World Treatment Patterns of Oral Antipsychotics and Associated Economic Burden in Patients with Schizophrenia in the United States
por: Martin, Amber, et al.
Publicado: (2022)

Persistence of Antipsychotic Use After Clozapine Discontinuation: A Real‐World Study Across Antipsychotics
por: Stam, Noraly, et al.
Publicado: (2020)

Cariprazine in Three Acute Patients with Schizophrenia: A Real-World Experience
por: Montes, Jose M, et al.
Publicado: (2021)

Osteoporosis Associated with Antipsychotic Treatment in Schizophrenia
por: Wu, Haishan, et al.
Publicado: (2013)

Treatment attrition rates and relevant risk factors in multiple myeloma: A real-world study in China
por: Tang, Wenjiao, et al.
Publicado: (2023)

Neutrophil-to-Lymphocyte Ratio Is Independently Associated With Severe Psychopathology in Schizophrenia and Is Changed by Antipsychotic Administration: A Large-Scale Cross-Sectional Retrospective Study
por: Zhou, Xia, et al.
Publicado: (2020)

Comparison of Long-Acting Injectable Antipsychotics With Oral Antipsychotics and Suicide and All-Cause Mortality in Patients With Newly Diagnosed Schizophrenia
por: Huang, Cheng-Yi, et al.
Publicado: (2021)

Efficacy and Tolerability of Second-Generation Antipsychotics in Children and Adolescents With Schizophrenia
por: Kumra, Sanjiv, et al.
Publicado: (2008)

The Efficacy and Heterogeneity of Antipsychotic Response in Schizophrenia: A Meta-analysis
por: McCutcheon, Robert A., et al.
Publicado: (2021)

A quantitative analysis of antipsychotic prescribing trends for the treatment of schizophrenia in England and Wales
por: Roberts, Rossela, et al.
Publicado: (2018)

Long-acting Injectable Antipsychotics during the COVID-19 pandemic in schizophrenia: An observational study in a real-world clinical setting
por: Barlati, Stefano, et al.
Publicado: (2022)

Real-World Effectiveness and Safety of Antipsychotics in Individuals at Clinical High-Risk for Psychosis: Study Protocol for a Prospective Observational Study (ShangHai at Risk for Psychosis-Phase 2)
por: Wu, GuiSen, et al.
Publicado: (2019)

Prediction of treatment response to antipsychotic drugs for precision medicine approach to schizophrenia: randomized trials and multiomics analysis
por: Guo, Liang-Kun, et al.
Publicado: (2023)

Safety and related factors of treatment with long-term atypical antipsychotic in Chinese patients with schizophrenia: observational study
por: Yu, Wenjuan, et al.
Publicado: (2021)

The personal, societal, and economic burden of schizophrenia in the People’s Republic of China: implications for antipsychotic therapy
por: Montgomery, William, et al.
Publicado: (2013)

Prevalence and Correlates of Cigarette Smoking among Chinese Schizophrenia Inpatients Receiving Antipsychotic Mono-Therapy
por: Xu, Yan-Min, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_lm4gj0ski4nr17i3sfng5hetdp